Eteplirsen

Records for this ingredient, by country (identity only).

ATC M09AX06 · 3 markets · 7 records

Eteplirsen 3 markets · 7 records Forms
Filters
MarketUS 4GB 2EU 1

US 4 records · 3 shown of 3 Source openFDA NDC Directory · Data as of 2026-10-23

  • 500 mg/10 mLinjectionManufacturer: Catalent Indiana, LLC ×2 also in GB
  • 100 mg/2 mLinjectionManufacturer: Catalent Indiana, LLC ×2 also in GB
  • 50 mg per mL / per unit basis not statedinjectionExondys 51

GB 2 records · 2 shown of 2 Source NHSBSA dm+d · Data as of 2026-10-19

EU 1 records · 0 shown of 0 Source European Commission · Data as of 2026-11-03 · some records have no stated strength · includes records with unknown status (not proof of sale)

EU centralised authorisation (EMA) — Authorised at EU level — not a record of sale in any single country. The EU register carries no strength, dosage form or pack size.

1 records · 0 manufacturers 1 registros · 0 fabricantes 1 个记录 · 0 个厂家 1 個記錄 · 0 個廠商

Some strengths are recorded without a per mL / per unit basis. They are shown as recorded and are not compared with other markets.

Side-by-side table

The same ingredient can carry completely different brand names in different countries, and the same name can point to a different ingredient. Listed by country — not interchangeable.

Discontinued, withdrawn or unverified-status products are hidden by default; Hong Kong and Australia records are shown as exceptions.